Inhibidores De Síntesis De ácidos Nucleicos

INHIBIDORES DE LA SINTESIS DE PROTEINAS 50S Mario Andrés Zamudio Burbano Estudiante IX Medicina Universidad de Antioquia

Cloranfenicol ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object]

Espectro ,[object Object],[object Object],[object Object],[object Object],[object Object]

Resistencia ,[object Object],[object Object],[object Object],[object Object],[object Object]

Indicaciones y dosis. ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Niveles séricos ,[object Object],[object Object],[object Object],[object Object]

Datos importantes ,[object Object],Cloranfenicol 250 mg cápsula $680 Cloranfenicol 1% ungüento oftálmico Cloranfenicol (estearato o palmitato) 125 mg/5 mL (2,5%) suspensión oral Cloranfenicol (succinato sódico) 1 g de base polvo para inyección $6.000 Cloranfenicol succinato sódico 0,5 solución oftálmica

Efectos Adversos ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Macrólidos ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Eritromicina ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Mecanismo de acción ,[object Object],[object Object],[object Object],[object Object],[object Object]

Actividad Antimicrobiana ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Resistencia ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Actividad no antimicrobiana ,[object Object],[object Object],[object Object],[object Object],[object Object]

Indicaciones primera elección ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Indicaciones fármaco alternativo ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Efectos adversos ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Efectos adversos ,[object Object],[object Object],[object Object],[object Object]

Interacciones farmacológicas ,[object Object]

Azitromicina Claritromicina ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Interacciones Claritromicina Azitromicina ,[object Object],[object Object]

Telitromicina ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Lincomicina y Clindamicina ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Actividad antimicrobiana, resistencia. ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Actividad antimicrobiana y resistencia. ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Indicaciones ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Efectos Adversos e interacciones. ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Quinupristina-dalfopristina ,[object Object],[object Object],[object Object]

Actividad Antimicrobiana ,[object Object],[object Object]

Resistencia ,[object Object],[object Object],[object Object],[object Object]

Indicaciones ,[object Object],[object Object],[object Object],[object Object],[object Object]

Adversos ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Linezolid ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Actividad antimicrobiana ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Uso clínico ,[object Object],[object Object],[object Object],[object Object],[object Object]

Resistencia ,[object Object],[object Object],[object Object]

Reacciones Adversas ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Bibliografía ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Inhibidores De Síntesis De ácidos Nucleicos

Recommandé

Recommandé

Contenu connexe

Tendances

Tendances (20)

Similaire à Inhibidores De Síntesis De ácidos Nucleicos

Similaire à Inhibidores De Síntesis De ácidos Nucleicos (20)

Plus de grupofarmacoudea

Plus de grupofarmacoudea (11)

Dernier

Dernier (20)

Inhibidores De Síntesis De ácidos Nucleicos

Notes de l'éditeur